Boris Revollo
Impact in
- Virology top 10%
- HIV Research and Treatment
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- HIV/AIDS drug development and treatment 7
- SARS-CoV-2 detection and testing 5
- SARS-CoV-2 and COVID-19 Research 5
- HIV/AIDS Research and Interventions 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Bonaventura Clotet (13 shared papers)Josep Maria Llibre (13 shared papers)Sebastián Videla (10 shared papers)Jordi Puig (2 shared papers)Guillem Sirera (8 shared papers)David Parés (6 shared papers)Roger Paredes (5 shared papers)Javier Corral (5 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)AIDS (4 papers)The Lancet HIV (3 papers)Scientific Reports (2 papers)The Journal of Infectious Diseases (2 papers)
- Partner nations
- SpainUnited StatesDenmark
In The Last Decade
Boris Revollo
33 papers receiving 450 citations
Peers
Comparison fields: 5 of 47
- Virology 55
- Modeling and Simulation 52
- Infectious Diseases 127
- Hepatology 56
- Epidemiology 91
Countries citing papers authored by Boris Revollo
This map shows the geographic impact of Boris Revollo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Revollo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Revollo more than expected).
Fields of papers citing papers by Boris Revollo
This network shows the impact of papers produced by Boris Revollo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Revollo. The network helps show where Boris Revollo may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Revollo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 65 | |
| 2 | 2019 | 42 | |
| 3 | 2022 | 41 | |
| 4 | 2019 | 23 | |
| 5 | 2013 | 20 | |
| 6 | 2021 | 20 | |
| 7 | 2016 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2024 | 16 | |
| 10 | 2022 | 15 | |
| 11 | 2017 | 14 | |
| 12 | 2022 | 14 | |
| 13 | 2018 | 13 | |
| 14 | 2018 | 13 | |
| 15 | 2018 | 12 | |
| 16 | 2022 | 12 | |
| 17 | 2019 | 10 | |
| 18 | 2019 | 10 | |
| 19 | 2023 | 10 | |
| 20 | 2014 | 9 |
About Boris Revollo
Boris Revollo is a scholar working on Infectious Diseases, Hepatology, Virology, Epidemiology and Surgery, having authored 37 papers that have together received 455 indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (7 papers), HIV/AIDS drug development and treatment (7 papers), Cervical Cancer and HPV Research (5 papers), SARS-CoV-2 detection and testing (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), HIV/AIDS Research and Interventions (4 papers), HIV Research and Treatment (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Virology (55 citations), Modeling and Simulation (52 citations), Infectious Diseases (127 citations), Hepatology (56 citations) and Epidemiology (91 citations). Boris Revollo has collaborated with scholars based in Spain, United States and Denmark. Frequent co-authors include Bonaventura Clotet, Josep Maria Llibre, Sebastián Videla, Jordi Puig, Guillem Sirera, David Parés, Roger Paredes, Javier Corral, Lı́dia Ruiz and Nuria Izquierdo‐Useros. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, AIDS, The Lancet HIV, Scientific Reports and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.